Therapeutic Pathways: Conditions

  • Dirk Hochlenert
  • Gerald Engels
  • Stephan Morbach
  • Stefanie Schliwa
  • Frances L. Game


Causal therapy of a diabetic foot on one hand tries to restore the reduced resilience and on the other to prevent the repetition of triggers. In this chapter, current treatment concepts for the most important conditions which reduce resilience (polyneuropathy and peripheral arterial disease) are described. Because infection might be an important aggravating factor, it is also considered in this chapter. Specific measures to reduce the effect of triggers are closely related to the type of the entity and are described some chapters ahead.


  1. 1.
    Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA, Boulton AJ. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22(1):157–62.CrossRefPubMedGoogle Scholar
  2. 2.
    Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990;13(5):513–21.CrossRefPubMedGoogle Scholar
  3. 3.
    Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, Uccioli L, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia. 2008;51(5):747–55. Scholar
  4. 4.
    Veves A, Manes C, Murray HJ, Young MJ, Boulton AJ. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care. 1993;16(8):1187–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Tesfaye S, Boulton AJ, Dickenson AH. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care. 2013;36(9):2456–65. Scholar
  6. 6.
    Siemionow M, Alghoul M, Molski M, Agaoglu G. Clinical outcome of peripheral nerve decompression in diabetic and nondiabetic peripheral neuropathy. Ann Plast Surg. 2006;57(4):385–90. Scholar
  7. 7.
    Aszmann O, Tassler PL, Dellon AL. Changing the natural history of diabetic neuropathy: incidence of ulcer/amputation in the contralateral limb of patients with a unilateral nerve decompression procedure. Ann Plast Surg. 2004;53(6):517–22.CrossRefPubMedGoogle Scholar
  8. 8.
    Nickerson DS, Rader AJ. Low long-term risk of foot ulcer recurrence after nerve decompression in a diabetes neuropathy cohort. J Am Podiatr Med Assoc. 2013;103(5):380–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Cornblath DR, Vinik A, Feldman E, Freeman R, Boulton AJ. Surgical decompression for diabetic sensorimotor polyneuropathy. Diabetes Care. 2007;30(2):421–2. Scholar
  10. 10.
    Morbach S, Furchert H, Groblinghoff U, Hoffmeier H, Kersten K, Klauke GT, Klemp U, et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care. 2012;35(10):2021–7. Scholar
  11. 11.
    Taylor SM, Cull DL, Kalbaugh CA, Senter HF, Langan EM III, Carsten CG 3rd, York JW, et al. Comparison of interventional outcomes according to preoperative indication: a single center analysis of 2,240 limb revascularizations. J Am Coll Surg. 2009;208(5):770–8.; ; discussion 778–780. Scholar
  12. 12.
    Apelqvist J, Elgzyri T, Larsson J, Londahl M, Nyberg P, Thorne J. Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients. J Vasc Surg. 2011;53(6):1582–1588.e1582. Scholar
  13. 13.
    Faglia E, Clerici G, Losa S, Tavano D, Caminiti M, Miramonti M, Somalvico F, Airoldi F. Limb revascularization feasibility in diabetic patients with critical limb ischemia: results from a cohort of 344 consecutive unselected diabetic patients evaluated in 2009. Diabetes Res Clin Pract. 2012;95(3):364–71. Scholar
  14. 14.
    Faglia E. Characteristics of peripheral arterial disease and its relevance to the diabetic population. Int J Low Extrem Wounds. 2011;10(3):152–66. Scholar
  15. 15.
    Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24(8):1433–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Apelqvist JA, Lepantalo MJ. The ulcerated leg: when to revascularize. Diabetes Metab Res Rev. 2012;28(Suppl 1):30–5. Scholar
  17. 17.
    Mills JL Sr, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, Andros G, Committee the Society for Vascular Surgery Lower Extremity Guidelines. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI). J Vasc Surg. 2013;59(1):220–34.e1–2. Scholar
  18. 18.
    Bauer H, Germann G, Gries FA, Imig H, Morbach S, Riepe G, Rothe U, et al. Nationale VersorgungsLeitlinie Typ-2-Diabetes: Präventions- und Behandlungsstrategien für Fußkomplikationen (Langfassung). Accessed 2006.Google Scholar
  19. 19.
    Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317–24.CrossRefPubMedGoogle Scholar
  20. 20.
    Emanuele MA, Buchanan BJ, Abraira C. Elevated leg systolic pressures and arterial calcification in diabetic occlusive vascular disease. Diabetes Care. 1981;4(2):289–92.CrossRefPubMedGoogle Scholar
  21. 21.
    Smith FC, Shearman CP, Simms MH, Gwynn BR. Falsely elevated ankle pressures in severe leg ischaemia: the pole test—an alternative approach. Eur J Vasc Surg. 1994;8(4):408–12.CrossRefPubMedGoogle Scholar
  22. 22.
    Katzberg RW, Haller C. Contrast-induced nephrotoxicity: clinical landscape. Kidney Int Suppl. 2006;100:S3–7. Scholar
  23. 23.
    Thomsen HS. Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur Radiol. 2006;16(12):2619–21. Scholar
  24. 24.
    Rolland Y, Duvauferrier R, Lucas A, Gourlay C, Morcet N, Rambeau M, Chaperon J. Lower limb angiography: a prospective study comparing carbon dioxide with iodinated contrast material in 30 patients. AJR Am J Roentgenol. 1998;171(2):333–7. Scholar
  25. 25.
    Bendermacher BL, Willigendael EM, Teijink JA, Prins MH. Medical management of peripheral arterial disease. J Thromb Haemost. 2005;3(8):1628–37. Scholar
  26. 26.
    Lumsden AB, Rice TW. Medical management of peripheral arterial disease: a therapeutic algorithm. J Endovasc Ther. 2006;13(Suppl 2):Ii19–29.CrossRefPubMedGoogle Scholar
  27. 27.
    Rümenapf G, Dentz J, Nagel N, Morbach S. Neue Konzepte zur interdisziplinären Versorgung von Patienten mit neuroischämischem diabetischem Fußsyndrom (DFS). Gefässchirurgie. 2012;17(5):327–33. Scholar
  28. 28.
    Neville RF, Attinger CE, Bulan EJ, Ducic I, Thomassen M, Sidawy AN. Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vasc Surg. 2009;23(3):367–73. Scholar
  29. 29.
    Alexandrescu V, Hubermont G. The challenging topic of diabetic foot revascularization: does the angiosome-guided angioplasty may improve outcome. J Cardiovasc Surg. 2012;53(1):3–12.Google Scholar
  30. 30.
    Taylor GI, Pan WR. Angiosomes of the leg: anatomic study and clinical implications. Plast Reconstr Surg. 1998;102(3):599–616; discussion 617–598CrossRefPubMedGoogle Scholar
  31. 31.
    Reekers JA, Lammer J. Diabetic foot and PAD: the endovascular approach. Diabetes Metab Res Rev. 2012;28(Suppl 1):36–9. Scholar
  32. 32.
    Varela C, Acin F, de Haro J, Bleda S, Esparza L, March JR. The role of foot collateral vessels on ulcer healing and limb salvage after successful endovascular and surgical distal procedures according to an angiosome model. Vasc Endovasc Surg. 2010;44(8):654–60. Scholar
  33. 33.
    Bergamini TM, George SM Jr, Massey HT, Henke PK, Klamer TW, Lambert GE Jr, Banis JC Jr, Miller FB, Garrison RN, Richardson JD. Pedal or peroneal bypass: which is better when both are patent? J Vasc Surg. 1994;20(3):347–55; discussion 355–346.CrossRefPubMedGoogle Scholar
  34. 34.
    Chantelau E, Tanudjaja T, Altenhofer F, Ersanli Z, Lacigova S, Metzger C. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial. Diabet Med. 1996;13(2):156–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Mutluoglu M, Uzun G, Turhan V, Gorenek L, Ay H, Lipsky BA. How reliable are cultures of specimens from superficial swabs compared with those of deep tissue in patients with diabetic foot ulcers? J Diabetes Complicat. 2012;26(3):225–9. Scholar
  36. 36.
    Lipsky BA, Peters EJ, Berendt AR, Senneville E, Bakker K, Embil JM, Lavery LA, Urbancic-Rovan V, Jeffcoate WJ, Foot International Working Group on Diabetic. Specific guidelines for the treatment of diabetic foot infections 2011. Diabetes Metab Res Rev. 2012;28(Suppl 1):234–5. Scholar
  37. 37.
    Lipsky BA, Peters EJ, Senneville E, Berendt AR, Embil JM, Lavery LA, Urbancic-Rovan V, Jeffcoate WJ. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev. 2012;28(Suppl 1):163–78. Scholar
  38. 38.
    Hochlenert D. Qualitätsbericht Netzwerk Diabetischer Fuß Köln und Umgebung 2006; 2007.Google Scholar
  39. 39.
    Yan J, Liu Y, Zhou B, Sun M. Pre-hospital delay in patients with diabetic foot problems: influencing factors and subsequent quality of care. Diabet Med. 2013.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Dirk Hochlenert
    • 1
  • Gerald Engels
    • 2
  • Stephan Morbach
    • 3
  • Stefanie Schliwa
    • 4
  • Frances L. Game
    • 5
  1. 1.Amb. Zentrum für DiabetologieEndoskopie & Wundheilung GemeinschaftspraxisKölnGermany
  2. 2.Department of Wound SurgerySt. Vinzenz Hospital and MVZ St. MarienKölnGermany
  3. 3.Department of Diabetes and AngiologyMarienkrankenhaus GmbHSoestGermany
  4. 4.Institute of Anatomy, Anatomy and Cell BiologyUniversity of BonnBonnGermany
  5. 5.Department of Diabetes and EndocrinologyDerby Hospitals NHS Foundation TrustDerbyUK

Personalised recommendations